US Broker Ratings

Zhengye Biotechnology Holding L (ZYBT): Investor Outlook Amidst a Challenging Year

Zhengye Biotechnology Holding L (NASDAQ: ZYBT) sits at the intersection of healthcare innovation and agricultural needs, focusing on the production and sale of veterinary vaccines. Based in Jilin, China, and..

National Research Corporation (NRC) Stock Analysis: A Healthcare Insights Leader with Robust ROE

National Research Corporation (NRC) stands at the intersection of healthcare and technology, providing critical analytics and insights that empower healthcare organizations to enhance both patient and employee experiences. Headquartered in..

Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 357.75% Potential Upside in the Healthcare Sector

Neuronetics, Inc. (NASDAQ: STIM), a prominent player in the medical devices industry, is capturing the attention of investors with its significant growth potential. Headquartered in Malvern, Pennsylvania, Neuronetics is known..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Unveiling a 446% Potential Upside

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stands at the forefront of biotechnology innovation, focused on developing mRNA-based therapeutic solutions for infectious diseases and rare genetic disorders. With its cutting-edge LUNAR..

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 41.68% Potential Upside in the Healthcare Sector

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector, primarily focuses on the design and manufacture of X-ray imaging components. Operating through two distinct segments—Medical and Industrial—Varex..

XOMA Royalty Corporation (XOMA) Stock Analysis: Unveiling a 148% Upside Potential

XOMA Royalty Corporation (NASDAQ: XOMA) offers an intriguing prospect for investors looking to tap into the biotechnology sector’s lucrative potential. As a biotech royalty aggregator, XOMA operates in a niche..

Outset Medical, Inc. (OM) Stock Analysis: Evaluating the 302% Upside Potential

Outset Medical, Inc. (NASDAQ: OM), a pioneer in the healthcare sector with its innovative hemodialysis solutions, presents a compelling investment opportunity, especially for risk-tolerant investors intrigued by high potential returns...

Viemed Healthcare, Inc. (VMD) Stock Analysis: Exploring a 78% Upside Potential for Investors

Viemed Healthcare, Inc. (NASDAQ: VMD) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Lafayette, Louisiana, Viemed specializes in providing home medical equipment..

NANO-X IMAGING LTD (NNOX) Stock Report: Exploring the 173% Potential Upside

Nano-X Imaging Ltd (NASDAQ: NNOX), a healthcare disruptor from Israel, is making waves in the medical devices industry with its cutting-edge digital X-ray technology. With a current market capitalization of..

Alpha Teknova, Inc. (TKNO) Stock Analysis: A Promising 118.98% Potential Upside Awaits Investors

Alpha Teknova, Inc. (TKNO), a key player in the healthcare sector, has been capturing investor attention with its innovative contributions to drug manufacturing, especially in the specialty and generic sub-industry...

Cytek Biosciences, Inc. (CTKB): Investor Outlook on a Potential 13.41% Upside

Cytek Biosciences, Inc. (NASDAQ: CTKB) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $648.27 million, this U.S.-based company is strategically..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Navigating Growth in the Biotech Sector with a 0.29% Potential Upside

Cidara Therapeutics, Inc. (NASDAQ: CDTX) stands at the forefront of the biotechnology sector with a focus on developing innovative therapies for critical medical conditions, notably invasive fungal infections and viral..

Erasca, Inc. (ERAS) Stock Analysis: Exploring a Potential 49% Upside in Precision Oncology

Erasca, Inc. (ERAS) has caught the attention of investors with its promising foray into the precision oncology sector. The San Diego-based biotechnology firm is at the forefront of developing innovative..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A 14.70% Upside Potential Awaits Investors

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a notable player in the biotechnology sector, is making waves with its promising pipeline and strong financial metrics. Headquartered in South San Francisco, California, Rigel..

Chevron Corporation (CVX) Stock Analysis: Exploring a 14.51% Upside Potential Amid Volatile Markets

As an energy giant with a market capitalization of $303.23 billion, Chevron Corporation (NYSE: CVX) remains a formidable player in the integrated oil and gas industry. Headquartered in Houston, Texas,..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Unlocking a 9.25% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands out in the competitive healthcare sector with its specialized focus on providing essential services to medical care facilities. With a market capitalization of..

Artivion, Inc. (AORT) Stock Analysis: 10% Potential Upside in Medical Device Innovations

Artivion, Inc. (AORT), a prominent player in the healthcare sector specializing in medical devices, has captured the attention of investors with its robust growth prospects and innovative product offerings. Headquartered..

MiMedx Group, Inc (MDXG) Stock Analysis: A Biotechnology Gem with 73% Potential Upside

MiMedx Group, Inc. (NASDAQ: MDXG) is making waves in the biotechnology sector, capturing investor attention with its innovative approach to healthcare solutions. Specializing in the development and distribution of placental..

Neogen Corporation (NEOG) Stock Analysis: Is a 14.54% Potential Upside Worth Your Investment?

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector, particularly within the Diagnostics & Research industry, has been attracting attention from investors keen on capitalizing on its potential..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Strong Buy Ratings and Nearly 96% Upside Potential

Celldex Therapeutics, Inc. (NASDAQ: CLDX) has captured the attention of investors with its promising pipeline in the biotechnology space, particularly in treatments targeting severe inflammatory, allergic, and autoimmune diseases. As..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds